¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"disease potential"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
¿µ¹® hyaline membrane disease ÇÑ±Û À¯¸®Áú¸·º´
¼³¸í   
  ÇãÆÄ ¼º¼÷µµÀÇ ¹Ì¼÷À¸·Î ÇãÆÄ²Ê¸®¸¦ ÆØÃ¢½Ã۴ ¹°Áú(Ç¥¸éȰ¼ºÁ¦)ÀÌ ºÎÁ·ÇÏ¿© È£Èí°ï¶õÀÌ ÃÊ·¡µÇ´Â º´À¸·Î¼­ ¹Ì¼÷¾Æ¿¡ È£¹ßÇϴµ¥, Ãâ»ý½Ã ÀӽűⰣº¸´Ùµµ ÇãÆÄ ¼º¼÷ Á¤µµ°¡ ´õ °ü¿©µÈ´Ù. ´ÜÀÏ º´À¸·Î¼­´Â »ç¸Á·üÀÌ °¡Àå ³ôÀ¸¸ç(¾à 30%), ½Å»ý¾ÆÀÇ ´ëÇ¥ÀûÀΠº´ÀÌ´Ù. ÀÓ»óÀûÀ¸·Î´Â ¹Ì¼÷¾Æ, »ýÈÄ 6~8½Ã°£³» È£Èí°ï¶õÁõ¼¼ ÃâÇö°ú »ýÈÄ 24~48½Ã°£ÀÇ Áõ»ó ¾ÇÈ­, »ýÈÄ 2~3Àϰ£ ÀΰøÀûÀ¸·Î »ê¼Ò¸¦ °ø±ÞÇÏÁö ¾ÊÀ¸¸é È£ÈíÀ» °è¼Ó½Ãų ¼ö°¡ ¾øÀ¸¸ç Á¡Á¡´õ »ê¼ÒÀÇ °ø±Þ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö¸ç, µ¿¸ÆÇ÷¾×¼ÓÀÇ »ê¼Ò³óµµ°¡ ³»·Á°¡°í ÀÌ»êȭź¼ÒÀÇ ³óµµ°¡ ³ôÀ¸¸ç, ÈäºÎ ¹æ»ç¼± ¼Ò°ßÀ» ÂüÀÛÇÏ¿© Áø´ÜÇÑ´Ù. È¯¾Æ´Â ¼÷·ÃµÈ °£È£ Àη°ú Ã·´Ü ÀÇ·á Àåºñ°¡ ¼³Ä¡µÈ ½Å»ý¾Æ ÁýÁß Ä¡·á½Ç¿¡¼­ Ä¡·áÇÏ¿©¾ß ÇÑ´Ù. ¿¹ÈĴ Áõ¼¼ÀÇ °æÁß¿¡ µû¶ó ´Ù¸£°í »ç¸Á·üÀº 30~50% µÈ´Ù. ¾î¶² ¾Æ±â¿¡ À־´Â Ä¡·á ÈÄ¿¡ ´«À̳ª ±â°üÁöÇãÆÄ °èÅë¿¡ Àå¾Ö¸¦ ÀÏÀ¸Å°´Â »ê¼ÒÁßµ¶ÁõÀÌ º¸°íµÇ°í ÀÖ´Ù.
¿µ¹® fibrocystic disease of breast ÇÑ±Û À¯¹æ ¼¶À¯³¶º´
¼³¸í   
  Á¥À» »ý»êÇϴ Á¥»ù³»¿¡ ¿ÏµÎÄᠶǴ ūÄá Å©±âÀÇ °áÀýÀÌ ¹ß»ýÇϴ Áõ¼¼¸¦ Æ¯Â¡À¸·Î Çϴ º´. 30~50´ëÀÇ ºÎÀο¡°Ô ÈçÈ÷ ¹ß»ýÇϸç, ±× ´ëºÎºÐÀº ¾çÂÊ À¯¹æ¿¡ µ¿½Ã¿¡ ¹ß»ýÇÑ´Ù. ÀÌ·¯ÇÑ °áÀýÀº µÎ ¼Õ°¡¶ô »çÀÌ¿¡ ³¢¿ö ÃËÁøÇÒ ¶§´Â ºÐ¸íÇÏÁö¸¸, È亮À» ¼Õ¹Ù´ÚÀ¸·Î ´©¸£¸é ¸í·áÇÏÁö ¾ÊÀ» Á¤µµ·Î ºÎµå·¯¿î °ÍÀÌ ¸¹´Ù. ±× ¹ß»ý ¿øÀο¡´Â ¿©·¯ °¡Áö ¼³ÀÌ ¸¹Àºµ¥, Á¥»ùÁ¶Á÷¿¡ ´ëÇÑ ¸¸¼ºÀûÀΠÀÚ±ØÀÌ ÁÖ¿øÀÎÀ̶ó »ý°¢µÇ°í ÀÖÀ¸¸ç, ±ØÈ÷ ¼­¼­È÷ ÁøÇàÇϴ °æ°ú¸¦ ¹â´Â´Ù. Áø´ÜÀº ÃËÁø, ÃÊÀ½ÆÄÁø´Ü µîÀ¸·Î Çϸç, ¾Ï°ú °¨º°ÀÌ °ï¶õÇÒ ¶§´Â Á¶Á÷ÀÇ ÀϺθ¦ Ã¤ÃëÇÏ¿© °Ë»çÇϴ »ý°ËÀÌ ÀÌ¿ëµÇ±âµµ ÇÑ´Ù.
¿µ¹® periodontal disease ÇÑ±Û Ä¡ÁÖº´
¼³¸í   
  ÀÕ¸ö°ú Ä¡¾Æ, ±×¸®°í ±× ÁÖÀ§ »ÀÀÇ ¿°Áõ°ú ÅðÇ༺ º¯È­¸¦ ¸»ÇÔ. Ä¡·á¿¡ À־ ÀÕ¸öÀÇ Á¦°Å°¡ ÇʼöÀûÀÌ´Ù. ÀÕ¸öÀÇ Á¦°Å´Â »õ·Î¿î ÀÕ¸öÀÇ »ý¼ºÀ» Á¶ÀåÇÑ´Ù.
¿µ¹® Crohn's disease ÇÑ±Û Å©·Ðº´
¼³¸í   
  ¸¸¼ºÀûÀ̰í Àç¹ßÀ» ÀßÇϴ âÀÚÀÇ ¿°ÁõÀ» Æ¯Â¡À¸·Î Çϴ º´. ÀåÀÇ º®Àº ¾ÈÂÊ¿¡¼­ºÎÅÍ Á¡¸·, Á¡¸·ÇÏÁ¶Á÷, ±ÙÀ°Ãþ, À帷ÀÇ 4°³ÀÇ ÃþÀ¸·Î ÀÌ·ç¾îÁ® Àִµ¥, Å©·Ðº´Àº ÀÌ ¸ðµç ÃþÀÇ ¿°ÁõÀ» µ¿¹ÝÇÑ´Ù. ÀåÀÇ ¸ðµç ºÎºÐ¿¡¼­ »ý±æ ¼ö°¡ ÀÖÁö¸¸ ÁַΠ¸·Ã¢ÀÚ¿Í ¿¬°áµÇ´Â Å«Ã¢ÀÚÀÇ ¸»´ÜºÎ¿¡ °¡Àå ¸¹ÀÌ »ý±ä´Ù. Ã¢ÀÚÀÇ ÀüÃþÀÇ ¿°ÁõÀ¸·Î ÀÎÇØ¼­ ÀåÀÇ Æó¼â³ª ±«¾çÀ» ¸¸µé¸ç Á¾Á¾ Ãµ°øµÈ´Ù.
¿µ¹® Paget's disease ÇÑ±Û ÆÄÁ¦Æ®º´
¼³¸í   
  1. »ÀÆÄÁ¦Æ®º´. º¯Çü¼º »À¿°. »ÀÈí¼ö ÈÄ »ÀÇü¼ºÀÌ ¹Ýº¹ÀûÀ¸·Î °úµµÇϰԠÀϾ´Â °ÍÀ¸·Î, »õ·Ó°Ô Çü¼ºµÈ »À´Â ¹«Áú¼­Ç졒ʱ¸Á¶ÀûÀ¸·Î °ß°íÇÏÁö ¸øÇÏ´Ù. »ÀÈí¼öÀÇ Áõ°¡°¡ ¹Ýº¹µÇ°í À̾ °úÀ׺¸¼ö¸¦ ²ÒÇÏ¿© ¾àÇ졒ʼ¯ÇüµÈ »ÀÀÇ ºÎÇǰ¡ Áõ°¡µÇ´Â °ÍÀ» Æ¯Â¡À¸·Î Çϴ »Àº´ÀÌ´Ù. ±ÃµÕ»ÀÀÇ ¸¸°î, ÆíÆò»ÀÀÇ º¯ÇüÀ» ÀÏÀ¸Å°°í, µ¿Åë ¹× º´Àû °ñÀýÀ» ¼ö¹ÝÇÑ´Ù. 2. À¯¹æÆÄÁ¦Æ®º´. Á¥²ÉÆÇ ¹× Á¥²ÀÁöÀÇ ¿°Áõ¼º ¾Ï¼º Áúº´À¸·Î¼­ º¸ÅëÀº Á¥»ù ¹× À¯¹æ ±íÀº °÷ÀÇ ¾ÏÀ» µ¿¹ÝÇÑ´Ù. º¸Åë Áß³âºÎÀο¡°Ô ¹ß»ýÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • phase boundary potential
    »ó°èÀüÀ§
  • receptor potential
    ¼ö¿ëüÀüÀ§
  • redox potential
    »êȭȯ¿øÀüÀ§
  • reduction potential
    ȯ¿øÀüÀ§
  • resonance potential
    °ø¸íÀüÀ§
  • resting membrane potential
    ¾ÈÁ¤¸·ÀüÀ§
  • reversal potential
    ¿ªÀüÀüÀ§
  • rheobasic potential
    ±âÀüÀ§
  • somatosensory evoked potential
    ¸ö°¨°¢À¯¹ßÀüÀ§°Ë»ç, ü¼º°¨°¢À¯¹ßÀüÀ§°Ë»ç
  • spike potential
    ±ØÆÄÀüÀ§
  • spinal evoked potential
    ô¼öÀ¯¹ßÀüÀ§
  • starting potential
    °³½ÃÀüÀ§
  • steady potential
    Ç×Á¤ÀüÀ§
  • streaming potential
    È帧ÀüÀ§
  • summating potential
    °¡ÁßÀüÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • receptor potential
    °¨¼ö±âÀüÀ§, °¨¼ö±âÀü¾Ð, ¼ö¿ëüÀü¾Ð
  • redox potential
    »êȭȯ¿øÀüÀ§
  • reduction potential
    ȯ¿øÀüÀ§
  • resonance potential
    °ø¸íÀüÀ§
  • resting membrane potential
    ¾ÈÁ¤¸·ÀüÀ§
  • reversal potential
    ¿ªÀüÀüÀ§, ¿ªÀüÀü¾Ð
  • rheobasic potential
    ±âÀüÀ§, ±âÀü¾Ð
  • segmental sensory evoked potential
    ºÎºÐ°¨°¢À¯¹ßÀüÀ§
  • sensory nerve action potential
    °¨°¢½Å°æÈ°µ¿ÀüÀ§
  • serrated action potential
    Åé´ÏȰµ¿ÀüÀ§
  • somatosensory evoked potential
    ¸ö°¨°¢À¯¹ßÀüÀ§°Ë»ç
  • spike potential
    ±ØÆÄÀüÀ§
  • spinal evoked potential
    ô¼öÀ¯¹ßÀüÀ§
  • starting potential
    °³½ÃÀüÀ§
  • steady potential
    Ç×Á¤ÀüÀ§, Ç×Á¤Àü¾Ð
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Burgers disease
    ¹ö°Åº´.
  • COPD=> chronic obstructive pulmonary disease
    ¸¸¼ºÆó»ö(¼â)¼º ÆóÁúȯ(Ø·àõøÍßáàõøËòðü´)
  • Carrions disease
    Ä«¸®¿Âº´.
  • Cavares disease
    Ä«¹Ù·¹º´ ¡ì°¡Á·¼º Áֱ⼺ ¸¶ºñ¡í.
  • Chagas-disease =Brazilian trypano somia sis
    »þ°¡½ºº´ ¡ì¾Æ¸Þ¸®Ä«Æ®¸®ÆÄ ³ë¼Ò¸¶Áõ¡í.
  • Charcot-Guinon disease
    ¼£Äà ±â³í º´
  • Charcot-Marie-Tooth disease
    »þ¸£ÄÚ-¸¶¸®-Åõ½ºº´.
  • Charcots disease
    »þ¸£ÄÚ º´(¡­Ü»).
  • Charlouis-disease
    »þ¸¦·çÀ̺´.
  • Chesters disease
    ü½ºÅͺ´.
  • Chiari-Frommel disease
    Ű¾Æ¸®ÇÁ·Ò¸áº´.
  • Chicago disease
    ½ÃÄ«°íº´.
  • Christmas disease
    Å©¸®½º¸¶½ºº´
  • Christmas disease
    Å©¸®½º¸¶½º º´
  • Christmas disease=hemophilia B
    Å©¸®½º¸¶½ºº´=Ç÷¿ìº´ B
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • ionization potential
    ÀÌ¿ÂÈ­(ûù)Àü¾Ð(ï³äâ).
  • maximal diastolic potential
    ÃÖ´ëÀ̿ϱâÀü¾Ð(õÌÓÞì¬èÐÑ¢ï³äâ)
  • membrane potential
    ¸·ÀüÀ§.
  • microphonic potential
    ¸¶ÀÌÅ©·ÎÆùÀüÀ§.
  • microphonic potential
    ¸¶ÀÌÅ©·ÎÆùÀüÀ§
  • migration potential
    À̵¿ÀüÀ§.
  • miniature end plate potential =MEPP
    ½Å°æ,»ý¸®,¾à¸®²¿¸¶Á¾ÆÇÀü¾Ð(ðû÷ùï³äâ)
  • miniature end plate potential =MEPP
    ¹Ì¼¼Á¾ÆÇÀüÀ§(Ú°á¬ðû÷ùï³êÈ).
  • miniature end plate potential =MEPP
    [½Å°æ,»ý¸®,¾à¸®]¹Ì¼¼Á¾ÆÇÀüÀ§(Ú°á¬ðû÷ùï³êÈ).
  • miniature potential
    ¹Ì¼¼ÀüÀ§(Ú°á¬ï³êÈ).
  • monophasic action potential
    ´Ü»ó¼º Ȱµ¿ Àü¾Ð.
  • muscle action potential
    ±ÙȰµ¿Àü¾Ð(ÐÉüÀÔÑ ï³äâ).
  • muscle action potential
    ±ÙȰµ¿ÀüÀ§(ÐÉüÀÔÑï³êÈ).
  • muscle action potential
    ±ÙȰµ¿ÀüÀ§(ÐÉüÀÔÑ ï³êÈ).
  • negative potential
    À½Àü¾Ð, À½ÀüÀ§.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • high-potential iron protein
    °íÀüÀ§(ÍÔï³êÈ) ö´Ü¹éÁú(ôÑÓ±ÛÜòõ)
  • ionization potential
    ÀÌ¿ÂÈ­(ûù) Àü¾Ð(ï³äâ)
  • junction potential
    Á¢ÇպΠÀüÀ§(ïÈùêÝ»ï³êÈ)
  • liquid junction potential
    ¾×üÁ¢Á¡ÀüÀ§(äûô÷ïÈïÇï³êÈ)
  • low-potential iron protein
    ÀúÀüÀ§ ö´Ü¹éÁú(î¸ï³êÈôÑÓ±ÛÜòõ)
  • membrane potential
    ¸·ÀüÀ§(دï³êÈ)
  • midpoint potential
    Áß°£Á¡ÀüÀ§(ñéÊàïÁï³êÈ)
  • operating potential
    ÀÛµ¿ÀüÀ§(íÂÔÑï³êÈ)
  • osmotic potential
    »ïÅõ´É(ß¶÷âÒö)
  • oxidation potential
    »êÈ­ ÀüÀ§(ß«ûùï³êÈ)
  • oxidation-reduction potential
    »êȭȯ¿ø ÀüÀ§(ß«ûùü½êªï³êÈ)
  • phosphate potential
    Àλê ÀüÀ§(×òß«ï³êÈ)
  • phosphate transfer potential
    ÀλêÀüÀÌ ÀüÀ§(×òß«ï®ì¹ï³êÈ)
  • phosphorylation potential
    ÀλêÈ­ ÀüÀ§(×òß«ûùï³êÈ)
  • phosphoryl transfer potential
    ÀλêÈ­ ÀüÀÌ ÀüÀ§(×òß«ûùï®ì¹ï³êÈ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • storage disease
    ÃàÀûÁõ
  • Tay-Sachs disease
    Å×ÀÌ-»è½ºº´
  • thromboembolic disease
    Ç÷Àü»öÀü¼ºÁúȯ
  • Tietzes disease+B701
    ƼÂź´
  • underlying disease
    ¿øÁúȯ, ±âÃÊÁúȯ
  • valvular disease
    ÆÇ¸·Áõ
  • valvular heart disease
    ÆÇ¸·¼º½ÉÁúȯ
  • wasting disease
    ¼Ò¸ðº´
  • Wilson's disease
    Àª½¼º´
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
IP icterus praecox; imaging plate; immune precipitate; immunoblastic plasma; immunoperoxidase technique...
LSEP left somatosensory evoked potential; lumbosacral somatosensory evoked potential
MP macrophage; matrix protein; mean pressure; melphalan and prednisone; melting point; membrane potenti...
RP radial pulse; radiopharmaceutical; rapid processing [of film]; Raynaud phenomenon; reactive protein;...
AR   1) Aortic Regurgitation
    = AI
  Echo¼Ò°ß
 &...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
CSEP Cortical somatosensory evoked potential
ERP early receptor potential
EPP End plate potential
EP Endocochlear DC potential
EP Endocochlear Potential
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Aran-Duchenne disease
    ¾Æ¶û-µÚ½Ã¿£´Àº´
    µ¿ÀǾî=s
  • arbovirus disease
    ¾Æ¸£º¸ ¹ÙÀÌ·¯½ºº´
  • arthropod viral disease
    ¾Æ¸£º¸ ¹ÙÀÌ·¯½º Áúȯ, ÀýÁöµ¿¹° ¸Å°³ ¹ÙÀÌ·¯½º Áúȯ, ÀýÁöµ¿¹° ¸Å°³¼º ¹ÙÀÌ·¯½º Áúȯ
    µ¿ÀǾî=arbovirus disease.
  • atopic disease
    ¾ÆÅäÇǼº Áúȯ
    À¯ÀüÀû ¼ÒÀÎÀ» °¡Áö ÀÓ»óÀû °ú¹ÎÁõ »óÅ ¶Ç´Â ¾Ë·¯Áö. Áï ¾î¶² Á¾·ùÀÇ ¾Ë·¯Áö¸¦ ÀÏÀ¸Å°±â ½¬¿î °æÇâÀº À¯ÀüµÇ³ª, ƯÀÌÀûÀÎ ÀÓ»óÇüÀÎ °íÃÊ¿­, õ½Ä, ½ÀÁø µîÀº À¯ÀüµÇÁö ¾Ê´Â´Ù. reaginÀ̶ó´Â ÀÌ»óÇÑ ÇüÀÇ Ç×ü°¡ Æ÷ÇԵǾî ÀÖÀ¸³ª, À̰ÍÀº ¸é¿ª ±Û·ÎºÒ¸°
  • autoallergic disease
    ÀÚ°¡ ¾Ë·¹¸£±â Áúȯ
  • autoimmune hemolytic disease
    ÀÚ°¡ ¸é¿ª¼º ¿ëÇ÷¼º Áúȯ
  • aviator's disease
    ºñÇà»çº´, Ç×°øº´
    ºñÇà»çÀÇ ±Þ¼º °íµµº´.
  • Azorean disease
    ¾ÆÁ¶·¹º´
    Æ÷¸£Åõ°¥ ¾ÆÁ¶·¹°è °¡Á·¿¡°Ô ¹ß»ýÇÏ´Â ÁßÃ߽Űæ°èÀÇ ÁøÇ༺ º¯¼º Áúȯ. »ó¿°»öü¼º ¿ì¼º ÇüÁú·Î¼­ À¯ÀüÇÏ¸ç ¿©·¯ °¡Áö ÇüÀÌ ÀÖ´Ù. ³× °¡Áö ±âº»ÇüÀÌ ÀÖÀ¸¸ç, Á¦ ¥°ÇüÀº Ãßü ¹× Ãßü¿Ü·ÎÀÇ º¯¼º, Á¦ ¥±ÇüÀº ¼Ò³ú, Ãßü, ¹× Ãßü¿Ü·Î º¯¼º, Á¦ ¥²ÇüÀº ¼Ò³ú º¯¼º°ú ¿øÀ§ºÎ °¨°¢¿îµ¿ ½Å°æº¯Áõ, Á¦ ¥³ÇüÀº ¿øÀ§ºÎ °¨°¢ ½Å°æº´ÁõÀ¸·Î ³ªÅ¸³­´Ù.
  • Baastrup's disease
    ¹Ù½ºÆ®·çÇÁ º´
    µ¿ÀǾî=kissing s
  • Ballet's disease
    ¹ß·¹ º´
    ¿Ü¾È±Ù ¸¶ºñ.
  • Ballingall's disease
    ¹ß¸µ°¥ º´
  • Bamberger's disease
    ¹ãº£¸£°Å º´
    ´Ù¸®ÀÇ µµ¾à °æ·Ã ¶Ç´Â ƽ.
  • Banti's disease
    ¹ÝƼ º´
    Ãʱ⿡´Â ºñÁ¾ ¹× ¹üÇ÷±¸ °¨¼ÒÁõÀ» µ¿¹ÝÇÏ´Â ºñÀåÀÇ ¿ø¹ß¼º ÁúȯÀ¸·Î ±â·ÏµÇ¾úÀ¸³ª, ÈÄ¿¡ ¹®¸Æ¾Ð Ç×Áø¿¡ ÀÇÇÑ ÀÌÂ÷ÀûÀÎ °ÍÀ¸·Î ÀÎÁ¤µÇ¾ú´Ù.
  • Barcoo disease
    ¹Ù¸£Äíº´
    µ¿ÀǾî=desert sore.
  • Barthelemy's disease
    ¹Ù¸£ÅÚ·¹¹Ì º´
    ¾ó±¼ÀÇ °áÇÙ¼º µÎâ ºñ½ÁÇÑ ÁÂâ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
Addison's disease <endocrinology> A rare endocrine disease that results from the underproduction of aldosterone and cortisol (hormones) by the adrenal glands.
Symptoms include weakness, low blood pressure, anaemia, low blood sugar and electrolyte abnormalities.
(27 Sep 1997)
adult-onset still's disease Although Still's disease was first described in children, it is known to begin in adults. See: Still's disease.
(12 Dec 1998)
Akabane disease A disease of cattle, sheep and goats, caused by the Akabane virus and characterised by foetal or neonatal arthrogryposis and hydranencephaly, abortions, and foetal death; the causative virus is transmitted by mosquitoes in Japan and by the midge Culicoides brevitarsis in Australia.
(05 Mar 2000)
akamushi disease See Typhus, scrub.
(12 Dec 1998)
Akureyri disease An epidemic disease characterised by stiffness of the neck and back, headache, diarrhoea, fever, and localised muscular weakness; restricted almost exclusively to adults, affecting women more than men; probably viral in origin.
Synonym: Akureyri disease, benign myalgic encephalomyelitis, epidemic myalgic encephalomyelitis, Iceland disease.
(05 Mar 2000)
Albers-Schonberg disease The formation of abnormally dense bone, as opposed to osteoporosis.
(18 Nov 1997)
Albert's disease Achillobursitis involving inflammation of the bursa between the Achilles tendon and the os calcis.
Synonym: Swediauer's disease.
(05 Mar 2000)
Albright's disease <syndrome> The abnormal development of multiple bones, hormonal disorder and brownish skin lesions.
(27 Sep 1997)
alcoholic liver disease <gastroenterology> Alcoholic cirrhosis is a condition of irreversible liver disease due to the chronic inflammatory and toxic effects of ethanol on the liver.
In cirrhosis, the liver cells are replaced by fibrous scar tissue. Fibrosis leads to the development of portal hypertension. The development of cirrhosis is directly related to the duration and quantity of alcohol consumption.
The manifestations of cirrhosis are related to the liver's inability to not adequately remove waste products from the bloodstream and the effects of portal hypertension.
(15 Nov 1997)
aleutian mink disease A slow progressive disease of mink caused by the aleutian mink disease virus. It is characterised by poor reproduction, weight loss, autoimmunity, hypergammaglobulinaemia, increased susceptibility to bacterial infections, and death from renal failure. The disease occurs in all colour types, but mink which are homozygous recessive for the aleutian gene for light coat colour are particularly susceptible.
(12 Dec 1998)
aleutian mink disease virus A species of parvovirus that causes a disease in mink, mainly those homozygous for the recessive aleutian gene which determines a desirable coat colour.
(12 Dec 1998)
alexander disease <radiology> Dysmyelinating disease, rare, sporadic, usually presents in 1st year, gradual enlargement of head (Differential diagnosis: Canavan disease), retardation, convulsion, spasticity CT findings: decreased density of white matter, frontal lobe predominance, with or without dilated lateral ventricles Diagnosis: brain biopsy
(12 Dec 1998)
Alexander's disease A rare, fatal central nervous system degenerative disease of infants, characterised by psychomotor retardation, seizures, and paralysis; megaloencephaly is associated with widespread leukodystrophic changes, especially in the frontal lobes.
(05 Mar 2000)
alkali disease A term applied to various animal poisonings of plant and mineral origin in arid regions under the belief that they were caused by the ingestion of alkaline waters; e.g., botulism of wild ducks, caused by feeding on decayed vegetation in nearly dried-up lakes.
(05 Mar 2000)
Almeida's disease <microbiology> A chronic fungal infection caused by Paracoccidioides brasiliensis.
It is characterised by primary pulmonary lesions with dissemination to many visceral organs.
Common findings include ulcerative granuloma lesions to the buccal mucosa (inner lining of the cheek) and nasal mucosa that extend to the surrounding skin. Generalised lymphangitis is also typical.
More commonly seen in South America and the tropics.
(15 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á